UNSPSC 51373430: Chlorpheniramine/hydrocodone/menthol/pseudoephedrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373430 Chlorpheniramine/hydrocodone/menthol/pseudoephedrine is a Commodity code under which state and local governments procure pharmaceutical products and controlled substances for healthcare delivery to populations in custody and community settings. The Washington State Department of Corrections and Seminole County, Florida have both recently solicited under this code for parenteral solutions, intravenous products, naloxone, and drug deactivation systems. State and local issuing bodies purchasing under this code include state departments of corrections, county health and community services agencies, and potentially other public health entities. Bidders must meet state business licensure, criminal background clearance (typically through state law enforcement agencies), and insurance requirements—including Commercial General Liability, Professional Liability, and Cyber Liability coverage with dollar thresholds ranging from $1 million to $2 million per occurrence. Vendors must also demonstrate documented experience in pharmaceutical preparation, delivery, and patient monitoring when relevant to the scope.

Recent activity spans at least Washington and Florida. The Washington State Department of Corrections issued RFQ RFQQK13020 on September 8, 2026, with a response deadline of October 7, 2026, seeking parenteral nutrition solutions, intravenous products, and controlled substances for eight correctional facilities across three regions (West, Central, and East), with contract performance through June 30, 2030 and firm pricing for two years. The procurement anticipates multiple awards (up to three bidders per region) and includes set-aside goals for small businesses (25%), minority-owned businesses (10%), women-owned businesses (6%), and veteran-owned businesses (5%). Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 drug deactivation systems annually for quarterly delivery to the county's Community Health Building in Sanford, with a two-year initial term and one-year renewal option. Both opportunities require electronic bid submission and establish fixed pricing frameworks with contract terms extending through 2030 and 2028 respectively.